RGNX REGENXBIO Inc.
Healthcare$6.34+0.00%OpenMarket Cap: $327.8M
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$22.50
Target (Median)
$19.00
Target Range
$12.00 - $45.00
Upside from current price: 254.9%
Rating Distribution
4 Strong Buy6 Buy1 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-15 | Barclays | maintain | Overweight | Overweight |
| 2026-05-15 | B of A Securities | maintain | Buy | Buy |
| 2026-03-09 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-03-06 | Morgan Stanley | maintain | Overweight | Overweight |
| 2026-02-10 | Goldman Sachs | maintain | Neutral | Neutral |
| 2026-02-10 | Chardan Capital | maintain | Buy | Buy |
| 2025-12-19 | Stifel | maintain | Buy | Buy |
| 2025-12-15 | Leerink Partners | maintain | Outperform | Outperform |
| 2025-11-20 | Chardan Capital | maintain | Buy | Buy |
| 2025-11-07 | RBC Capital | maintain | Outperform | Outperform |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-2.92 | $267.7M | 6 |
| Sun Dec 31 | $-1.40 | $423.2M | 5 |
| Mon Dec 31 | $1.49 | $650.0M | 1 |
| Tue Dec 31 | $5.45 | $937.9M | 1 |